Figures & data
Figure 1a and c. Axial T1-weighted contrast-enhanced scans (3,0T, TR 550, TE 13) after radiochemotherapy but before treatment with adjuvant TMZ and intrathecal DepoCyte showing widespread subependymal enhancement (a, arrow), parenchymal metastases of the occipital lobe (c, arrow) with perifocal edema (a, arrowhead). b and d. Corresponding images (3,0T, TR 550, TE 13) 12 months later without evidence of leptomeningeal or subependymal lesions (b, arrow) while the cerebral parenchymal metastases (d, arrow) and the perifocal edema (b, arrowhead) increased in size.
![Figure 1a and c. Axial T1-weighted contrast-enhanced scans (3,0T, TR 550, TE 13) after radiochemotherapy but before treatment with adjuvant TMZ and intrathecal DepoCyte showing widespread subependymal enhancement (a, arrow), parenchymal metastases of the occipital lobe (c, arrow) with perifocal edema (a, arrowhead). b and d. Corresponding images (3,0T, TR 550, TE 13) 12 months later without evidence of leptomeningeal or subependymal lesions (b, arrow) while the cerebral parenchymal metastases (d, arrow) and the perifocal edema (b, arrowhead) increased in size.](/cms/asset/fd43ad56-65c3-4543-9de5-b8d23c85a38d/ionc_a_586001_uf0001_b.gif)